These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


218 related items for PubMed ID: 231013

  • 1. Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration.
    Jänne O, Kauppila A, Kontula K, Syrjälä P, Vihko R.
    Int J Cancer; 1979 Nov 15; 24(5):545-54. PubMed ID: 231013
    [No Abstract] [Full Text] [Related]

  • 2. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.
    Ehrlich CE, Young PC, Cleary RE.
    Am J Obstet Gynecol; 1981 Nov 01; 141(5):539-46. PubMed ID: 6457531
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro binding of progesterone by the human endometrium during the menstrual cycle and by hyperplastic, atrophic, and carcinomatous endometrium.
    Haukkamaa M, Karjalainen O, Luukkainen T.
    Am J Obstet Gynecol; 1971 Sep 15; 111(2):205-10. PubMed ID: 5098589
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The level of steroid hormone receptors in endometrial cancer].
    Bieglmayer C, Spona J, Ulm R, Husslein P.
    Acta Univ Palacki Olomuc Fac Med; 1981 Sep 15; 101():159-65. PubMed ID: 6211045
    [No Abstract] [Full Text] [Related]

  • 10. Progesterone binding by human endometrial tissue during the proliferative and secretory phases of the menstrual cycle and by hyperplastic and carcinomatous endometrium.
    Rodriquez J, Sen KK, Seski JC, Menon M, Johnson TR, Menon KM.
    Am J Obstet Gynecol; 1979 Mar 15; 133(6):660-5. PubMed ID: 426021
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antioxidant status and sex hormones in women with complex endometrial hyperplasia.
    Pejić S, Todorović A, Stojiljković V, Pavlović I, Gavrilović L, Popović N, Pajović SB.
    Cell Mol Biol (Noisy-le-grand); 2016 Sep 30; 62(11):51-56. PubMed ID: 27755952
    [Abstract] [Full Text] [Related]

  • 14. Cytosol oestradiol and progesterone receptors in endometrial hyperplasia and adenocarcinoma: determination by single saturating dose exchange assays.
    Elliott PM, Krozowski Z, Jansen RP.
    Aust N Z J Obstet Gynaecol; 1980 Nov 30; 20(4):199-204. PubMed ID: 6940562
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Endometrial hyperplasia: a prospective randomized study of histopathology, tissue steroid receptors and plasma steroids after abrasio, with or without high dose gestagen treatment.
    Lindahl B, Alm P, Fernö M, Norgren A.
    Anticancer Res; 1990 Nov 30; 10(3):725-30. PubMed ID: 2142394
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Medroxyprogesterone acetate, estradiol, FSH and LH in peripheral blood after intramuscular administration of Depo-ProveraR to women.
    Jeppsson S, Johansson.
    Contraception; 1976 Oct 30; 14(4):461-69. PubMed ID: 975831
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.